Reuters logo
BRIEF-Impax Laboratories Q2 GAAP loss per share $0.28
2017年8月9日 / 上午11点14分 / 1 个月前

BRIEF-Impax Laboratories Q2 GAAP loss per share $0.28

Aug 9 (Reuters) - Impax Laboratories Inc

* Impax reports solid second quarter 2017 results with total revenues increasing 17% to $202 million

* Q2 adjusted earnings per share $0.18

* Q2 GAAP loss per share $0.28

* Q2 revenue $202.1 million versus I/B/E/S view $195.6 million

* Q2 earnings per share view $0.14 -- Thomson Reuters I/B/E/S

* Reaffirms full year 2017 EPS guidance​‍

* 2017 adjusted gross margins as a percent of total revenue are expected to be approximately 47% to 49%​

* Sees 2017 ‍capital expenditures of approximately $25 million to $30 million​

* Sees ‍full year 2017 adjusted net income per share of $0.55 to $0.70​

* FY2017 earnings per share view $0.66 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below